🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our new cover is out! Check it out! Thanks to my fave person in the world and amazing artist @Brik20744903 and to all the coauthors! Federica Giordano STEFANIA LENNA @RiccardoRampad5 Yustein Lab Ava Brozovich Houston Methodist MD----> onlinelibrary.wiley.com/doi/abs/10.100…

Wishing everyone a very happy and healthy New Year! #Happy2022

OMG! The Faris Foundation Turns 3! - mailchi.mp/4247b9814c5c/f…

Celebrating Faris’ birthday and the 3-year anniversary of the Faris Foundation today!

Happy to share our new publication on RMS! K-Ras and p53 mouse model with molecular characteristics of human rhabdomyosarcoma and translational applications journals.biologists.com/dmm/article/15…

#EditorsChoice from our RAS pathway special issue is Yustein Lab's paper characterising advanced 🐁 model of paediatric #sarcoma that can enable development of novel therapies Chosen by guest Editors Arvin Dar Donita Brady of Brady Lab UPenn 💡journals.biologists.com/dmm/article/15… 📰journals.biologists.com/dmm/article/15…

New Research: Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications: Osteosarcoma is a primary malignant tumor that tends to threaten children and adolescents, and the 5-year event-free survival… frontiersin.org/articles/10.33… #immunology

😁FACTOR22PANEL: Liquid Biopsies & Biomarkers 👉Discussing what we can learn from osteosarcoma blood & tissue samples including best practices for optimizing & allocating tissue samples, & the latest on liquid biopsies for osteosarcoma. mibagents.org/factor22

John’s journey with Ewing's Sarcoma began with back pain, and tingling and numbness in his leg. He went through grueling treatment; unfortunately, John’s passed away on June 8th, 2019. His family established the John Phillip Douglass Fund. Story/donate : reininsarcoma.org/sarcoma-story-…

👏MIB Agents is awarding six OutSmarting Osteosarcoma grants totaling $450,000 in 2022! 📰For the full press release on these exciting awards and FACTOR: prn.to/3tIsJyb #outsmartingosteosarcoma #osteosarcoma #osteosarcomaresearchgrant #researchgrant #becauseofyou

🔊Today we share #Review "Recent Insights into Therapy Resistance in #Osteosarcoma" 👏by @ZPrudowskyMD and Jason T. Yustein Yustein Lab BCMHouston Texas Children's Access the paper here👉mdpi.com/2072-6694/13/1… Keywords: osteosarcoma; chemotherapy resistance

🔬Dr. Jason Yustein discussed his research - evaluating combination therapies to improve immune-mediated approaches for osteosarcoma. 💬Watch the full episode here or listen where you podcast! youtu.be/T_0vTzLySu4 ✨This episode is sponsored by our friends at The Osteosarcoma Institute.

The Texas Children's O'Quinn Medical Tower and the fountains at Texas Children's Hospital West Campus and The Woodlands were lit up gold in recognition of #ChildhoodCancerAwarenessMonth! Join us in raising awareness during the month of September

During this year's #BoneCancerAwarenessWeek we held our third annual Ewing sarcoma research meeting 🔬🧬 Together with Children with Cancer UK we brought 100 delegates together to accelerate desperately needed research into Ewing sarcoma 👉 ow.ly/pmnX50LFONK #Research #UntilTheresACure

Winship investigator Jason Yustein, MD, PhD, will receive a grant from the Osteosarcoma Institute (The Osteosarcoma Institute) in support of his research using combination therapies to improve immune-mediated approaches for high-risk osteosarcoma. ➡️ fal.cn/3u36t

Here we are: Federica Giordano and STEFANIA LENNA made this happened, together with the support of a lot of others folks (cannot tag all) in collaboration with Yustein Lab cancer-nano.biomedcentral.com/articles/10.11…

New Research: Single-cell RNA datasets and bulk RNA datasets analysis demonstrated C1Q+ tumor-associated macrophage as a major and antitumor immune cell population in osteosarcoma: Background Osteosarcoma is the most frequent primary bone… frontiersin.org/articles/10.33… #immunology

Congratulations to Dr. Jason Yustein (Yustein Lab) with Winship Cancer Institute of Emory University and Children's for his $100,000 research grant through MIB Agents Osteosarcoma Alliance to study pediatric osteosarcoma

I was honored to present the 2023 AACR-St Baldrick’s Foundation Award for Outstanding Achievement in Pediatric Cancer Research to Olivier Delattre.

MYC regulates CSF1 expression via microRNA 17/20a to modulate tumor-associated macrophages in osteosarcoma: buff.ly/43jlpbe Yustein Lab Emory School of Medicine #Oncology